Aspen Aerogels (ASPN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
19 Aug, 2026Executive summary
Q2 2026 revenue reached $49.8 million, up 32% quarter-over-quarter, driven by strong thermal barrier sales and deferred revenue recognition from a GM settlement, but down from $78.0 million year-over-year due to regulatory impacts on North American EV incentives.
PyroThin thermal barrier business saw 81% quarter-over-quarter growth, with expanding European OEM awards, including Jaguar Land Rover, and a raised 2026 revenue outlook for Europe.
The staged restart of the East Providence plant after an April 2026 incident avoided major supply disruptions, with full capacity expected in H1 2027.
Net loss for Q2 2026 was $23.3 million, including $8.9 million in property damage from the East Providence incident, offset by insurance receivable.
Ended Q2 2026 with $153.4 million in cash, cash equivalents, and restricted cash.
Financial highlights
Q2 2026 revenue: $49.8 million (Energy Industrial: $20.4 million; Thermal Barrier: $29.5 million, including $4.9 million deferred revenue from GM).
Gross profit for Q2 2026 was $3.3 million (7% margin); adjusted gross profit: $8.6 million (17% margin), excluding $5.3 million in incident-related costs.
GAAP net loss: $23.3 million in Q2; adjusted net loss: $17.9 million; adjusted EBITDA: negative $6.6 million.
Q2 cash and equivalents: $153.4 million; term loan balance: $79.5 million; revolver balance: $10.9 million.
Net cash used in financing activities was $19.9 million for the first half of 2026.
Outlook and guidance
Q3 2026 revenue expected between $65 million and $80 million; adjusted EBITDA forecasted at $7 million to $15 million, including $5–$10 million in incident-related add-backs.
Q3 2026 net loss projected between $6 million and $9 million, or $0.07 to $0.11 per share.
2026 European thermal barrier revenue outlook raised to $20–$30 million; 2027 target: $40–$60 million.
Energy industrial segment expected to maintain ~20% growth in 2027, with a path to $200 million annual revenue without major capital investment.
Capital expenditures for FY 2026, excluding East Providence restoration, are expected to be less than $10 million.
Latest events from Aspen Aerogels
- Aerogel technology drives scalable growth in energy and EV markets, with profitability in sight.ASPN
Investor presentation - Raised European revenue outlook, robust cost controls, and dual supply strategy drive growth.ASPN
Oppenheimer 29th Annual Technology, Internet & Communications Conference - Strong margin gains, new OEM launches, and DOE-backed expansion drive robust growth outlook.ASPN
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 - All proposals passed, including director elections and board declassification.ASPN
AGM 2026 - Q1 2026 revenue dropped, but net loss improved and strong cash reserves support recovery.ASPN
Q1 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and board structure.ASPN
Proxy filing - Proxy covers director elections, auditor ratification, executive pay, and board declassification.ASPN
Proxy filing - Annual meeting covers director elections, pay, auditor ratification, and board declassification.ASPN
Proxy Filing - Record 2024 revenue, margin expansion, and capital-light strategy support resilient outlook.ASPN
Q4 2024